Cardiopulmonary function in paediatric post-COVID-19: a controlled clinical trial
European Journal of Pediatrics · 2024
DOI: 10.1007/s00431-024-05421-w ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Pediatrics, 2024. Verfasst von Isabelle Schoeffl und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Cardiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Loschgestrasse 15, 91054, Erlang…. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Erlangen.
Abstract (Originalsprache)
Recently, the importance of post-COVID-19 in children has been recognized in surveys and retrospective chart analysis. However, objective data in the form of cardiopulmonary exercise test as performed in adults suffering from this condition are still lacking. This study aimed to investigate the cardiopulmonary effects of post-COVID-19 on children and adolescents. In this cross-sectional study (the FASCINATE study), children fulfilling the criteria of post-COVID-19 and an age- and sex-matched control group underwent cardiopulmonary exercise testing on a treadmill and completed a questionnaire with regard to physical activity before, during and after the infection with SARS-CoV-2. We were able to recruit 20 children suffering from post-COVID-19 (mean age 12.8 ± 2.4 years, 60% females) and 28 control children (mean age 11.7 ± 3.5 years, 50% females). All participants completed a maximal treadmill test with a significantly lower $$\dot{{\text{V}}}{{\text{O}}}_{2}{\text{peak}}$$ V ˙ O 2 peak in the post-COVID-19 group (37.4 ± 8.8 ml/kg/min vs. 43.0 ± 6.7 ml/kg/min. p = 0.019). This significance did not persist when comparing the achieved percentage of predicted $$\dot{{\text{V}}}{{\text{O}}}_{2}{\text{peak}}$$ V ˙ O 2 peak . There were no significant differences for oxygen pulse, heart rate, minute ventilation or breathing frequency. Conclusion : This is the first study to investigate post-COVID-19 in children using the cardiopulmonary exercise test. Although there was a significantly reduced $$\dot{{\text{V}}}{{\text{O}}}_{2}{\text{peak}}$$ V ˙ O 2 peak in the post-COVID-19 group, this was not true for the percent of predicted values. No pathological findings with respect to cardiac or pulmonary functions could be discerned. Deconditioning was the most plausible cause for the experienced symptoms. Trial registration : clinicaltrials.gov, NCT054445531, Low-field Magnetic Resonance Imaging in Pediatric Post Covid-19—Full Text View—ClinicalTrials.gov. What is Known: • The persistence of symptoms after an infection with SARS-CoV 2, so-called post-COVID-19 exists also in children. • So far little research has been conducted to analyze this entity in the pediatric population. What is New: • This is the first study proving a significantly lower cardiopulmonary function in pediatric patients suffering from post-COVID-19 symptoms. • The cardiac and pulmonary function appear similar between children suffering from post-COVID-19 and those who don’t, but the peripheral muscles seem affected.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Cardiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Loschgestrasse 15, 91054, Erlangen, Germany. Isabelle.schoeffl@me.com.
- School of Clinical and Applied Sciences, Leeds Beckett University, Leeds, LS13HE, UK. Isabelle.schoeffl@me.com.
- Department of Pediatrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Loschgestrasse 15, 91054, Erlangen, Germany.
- Department of Pediatric Cardiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Loschgestrasse 15, 91054, Erlangen, Germany.
- Department of Radiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Loschgestrasse 15, 91054, Erlangen, Germany.
- Department of Pediatric Cardiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Loschgestrasse 15, 91054, Erlangen, Germany. Annika.weigelt@uk-erlangen.de.
Förderung
- Universitätsklinikum Erlangen
Zitieren
APA
Schoeffl, I., Raming, R., Tratzky, J. P., Regensburger, A. P., Kraus, C., Waellisch, W., Trollmann, R., Woelfle, J., Dittrich, S., Heiss, R., Knieling, F., & Weigelt, A. (2024). Cardiopulmonary function in paediatric post-COVID-19: a controlled clinical trial. European Journal of Pediatrics. https://doi.org/10.1007/s00431-024-05421-w
Vancouver
Schoeffl I, Raming R, Tratzky JP, Regensburger AP, Kraus C, Waellisch W, et al. Cardiopulmonary function in paediatric post-COVID-19: a controlled clinical trial. European Journal of Pediatrics. 2024. doi:10.1007/s00431-024-05421-w
BibTeX
@article{Schoeffl2024,
author = {Schoeffl, Isabelle and Raming, Roman and Tratzky, Jan-Philipp and Regensburger, Adrian P and Kraus, Calvin and Waellisch, Wolfgang and Trollmann, Regina and Woelfle, Joachim and Dittrich, Sven and Heiss, Rafael and Knieling, Ferdinand and Weigelt, Annika},
title = {Cardiopulmonary function in paediatric post-COVID-19: a controlled clinical trial},
journal = {European Journal of Pediatrics},
year = {2024},
doi = {10.1007/s00431-024-05421-w}
}
EUVIMED